Acetyl-CoA produced in mitochondria from carbohydrate or amino acid catabolism needs to reach the cytosol to initiate de novo synthesis of fatty acids. All eukaryotes analyzed so far use a citrate/malate shuttle to transfer acetyl group equivalents from the mitochondrial matrix to the cytosol. Here we investigate how this acetyl group transfer occurs in the procyclic life cycle stage of Trypanosoma brucei, a protozoan parasite responsible of human sleeping sickness and economically important livestock diseases. Deletion of the potential citrate lyase gene, a critical cytosolic enzyme of the citrate/malate shuttle, has no effect on de novo biosynthesis of fatty acids from 14 C-labeled glucose, indicating that another route is used for acetyl group transfer. Because acetate is produced from acetyl-CoA in the mitochondrion of this parasite, we considered genes encoding cytosolic enzymes producing acetyl-CoA from acetate. We identified an acetyl-CoA synthetase gene encoding a cytosolic enzyme (AceCS), which is essential for cell viability. Repression of AceCS by inducible RNAi results in a 20-fold reduction of 14 C-incorporation from radiolabeled glucose or acetate into de novo synthesized fatty acids. Thus, we demonstrate that the essential cytosolic enzyme AceCS of T. brucei is responsible for activation of acetate into acetyl-CoA to feed de novo biosynthesis of lipids. To date, Trypanosoma is the only known eukaryotic organism that uses acetate instead of citrate to transfer acetyl groups over the mitochondrial membrane for cytosolic lipid synthesis.
Trypanosoma brucei is an unicellular eukaryote, belonging to the protozoan order Kinetoplastida, that causes sleeping sickness in humans and economically important livestock diseases. This parasite undergoes a complex life cycle during transmission from the bloodstream of a mammalian host (bloodstream stages of the parasite) to the alimentary tract (procyclic stage) and salivary glands (epimastigote and metacyclic stages) of a bloodfeeding insect vector, the tse-tse fly. In addition to their relevance for health and development in subsaharan Africa, trypanosomes are famous for a variety of very unusual genetic and biochemical features that stimulate broad scientific and evolutionary interest. These include exotic mechanisms of gene expression like polycistronic transcription of genes (1) , maturation of premessenger RNA by trans-splicing and extensive editing of mitochondrial RNAs (2, 3) , and sophisticated mechanisms of immune evasion like antigenic variation and antibody endocytosis (4, 5) . In the context of this report, metabolic peculiarities like the compartmentalization of glycolysis in glycosomes, which are peroxisomelike organelles (6) , the presence of a single, developmentally regulated mitochondrion per cell with unusual enzyme activities (7, 8) , energy metabolism (9) and unusual pathways for de novo synthesis of fatty acids (10) are noteworthy. Indeed, whereas most cells use either a type I or type II synthase for de novo fatty acid synthesis, T. brucei is the only known organism using a third mechanism for this process. This parasite uses microsomal elongases to synthesize short-, medium-, and long-chain fatty acids from butyryl-CoA, by using malonyl-CoA as a C2 donor, whereas other organisms only can extend premade medium and long FAs by elongases to make long and very long fatty acyl chains (11) . In addition, we show here that the procyclic trypanosomes also use a pathway to produce cytosolic acetyl-CoA to feed de novo biosynthesis of fatty acids.
In nonphotosynthetic eukaryotes, nearly all of the acetyl-CoA used in fatty acid synthesis is formed in mitochondria from pyruvate oxidation and from the catabolism of the carbon skeletons of amino acids. It is widely accepted that all eukaryotes analyzed so far use the citrate/malate shuttle to transfer acetyl group equivalents from the mitochondrial matrix to the cytosol across the acetyl-CoA-impermeable mitochondrial inner membrane [see (12) ]. In this shuttle, intramitochondrial acetyl-CoA first reacts with oxaloacetate to form citrate, in the citric acid cycle (TCA) reaction catalyzed by citrate synthase (CS). Citrate passes through the mitochondrial inner membrane on a citrate transporter or a citrate/malate exchanger, and is converted back to acetyl-CoA and oxaloacetate by the cytosolic citrate lyase (CL) (see Fig. 1 ). In trypanosomes, existence of a citrate/malate shuttle was assumed to meet the needs of cytosolic fatty acid biosynthesis, although this view is not supported by any experimental data (11, 13) . Here we demonstrate that this assumption is incorrect for the procyclic stage of T. brucei. Instead, this parasite expresses a cytosolic ''AMP forming'' acetyl-CoA synthetase (AceCS), which is essential for incorporation of radiolabeled glucose (or acetate) into fatty acids and essential for growth. Thus, acetyl-CoA is converted into acetate in the mitochondrion (7) , which cross the mitochondrial inner membrane to be converted into acetyl-CoA by the cytosolic AceCS. We have demonstrated that acetate can be used to exchange acetyl group equivalents between the mitochondrial and cytosolic compartments.
Results
A Citrate/Malate Shuttle Is Not Required for Lipid Biosynthesis. It was assumed by analogy (8) that acetyl-CoA is exchanged in try-panosomes by a putative citrate/malate shuttle between the mitochondrion, where it is produced, and the cytosol, where it feeds de novo lipid synthesis. This shuttle requires 2 citrate forming/consuming enzymes (the mitochondrial CS and the cytosolic CL) and a citrate/malate exchanger or a citrate transporter present in the mitochondrial inner membrane ( Fig. 1 ). Whereas putative CS and CL genes have been identified in trypanosomatid genomes (8), a functional role of a citrate shuttle remains to be proven. To investigate the role of the putative CL gene (Tb927.8.6820, http://www.genedb.org/genedb/tryp/) in lipid biosynthesis of procyclic trypanosomes, we have generated 3 independent CL knock-out mutant cell lines (⌬cl/⌬cl-B6, -C9, and -E9) by replacing both CL alleles by selectable markers in the procyclic AnTat1.1-1313 cell line. Deletion of both alleles was confirmed by PCR ( Fig. S1B ) and RT-PCR ( Fig. S1C ). These mutant clones are viable, although their population doubling time is increased (16.6, 16.7, and 14.6 h, respectively) compared with the AnTat1.1-1313 parental cell line (12.5 h) .
The genetic data are compatible with negative results obtained with SB-204990, the cell-penetrant ␥-lactone prodrug of the potent ATP citrate-lyase inhibitor SB-201076 (K i ϭ l M for human enzyme) [(14) , kindly provided by SmithKline Beecham Pharmaceuticals]. Up to 100 M did not induce any effect on growth of procyclic trypanosomes of wild type and ⌬asct/⌬asct knock-out cell lines [reduced acetate production (7) , see below and Table S1 ], whereas 30 M almost completely inhibited lipid synthesis in cultured mammalian cells (12, 14) . In T. brucei, toxicity of SB204990 was only observed after 68 h of incubation with Ͼ200 M. It should be noted that we have no proof that SB204990 uptake, prodrug conversion and CL inhibition are effective in T. brucei. To directly investigate a role of the putative CL gene in lipid biosynthesis, a quantitative analysis of 14 Clabeled lipids produced from D-[U-14 C]-glucose was performed on the ⌬cl/⌬cl and parental cell lines. The parasites were incubated in SDM80 medium containing D-[U-14 C]-glucose and L-proline as the main carbon sources (without L-threonine, which is a major source of acetyl-CoA in standard growth conditions (15) ). Under these conditions, acetyl-CoA and glycerol-3-phosphate (G3P) produced from D-[U-14 C]-glucose catabolism ( Fig. 1 ) are major precursors for label incorporation into the fatty acid and glycerol parts, respectively, of the glycerolipids. Indeed, L-proline is a poor acetyl-CoA producer and does not produce G3P in the presence of D-glucose (16) . The major fatty-acid containing lipids labeled de novo were the phospholipids (PC, phosphatidylcholine; PE, phosphatidylethanolamine; PI, phosphatidylinositol) and the neutral lipids (TAG, triacylglycerols; FFA, free fatty acids). No significant change in 14 C-incorporation into individual lipids was seen in the 3 ⌬cl/⌬cl clones compared with parental cells (Fig. 2) , which clearly demonstrated that the conventional citrate/malate shuttle is not essential for fatty acid biosynthesis in procyclic trypanosomes.
A Functional Acetyl-CoA Synthetase (AceCS) Gene in T. brucei. With the aim of characterizing new acetate consuming or producing enzymes in T. brucei, we searched for sequences related to acetaldehyde dehydrogenase (EC: 1.2.1.3), acetyl-CoA hydrolase (EC: 3.1.2.1), phosphate acetyltransferase (EC: 2.3.1.8), acetate kinase (EC: 2.7.2.1), ''ADP-forming'' acetyl-CoA synthetase (EC: 6.2.1.13), and ''AMP-forming'' acetyl-CoA synthetase (EC: 6.2.1.1) in the GeneDB T. brucei genome database (http://www.genedb.org/genedb/tryp/) using TBLASTN. Only the Tb927.8.2520 sequence encoding a protein homologous to ''AMP-forming'' acetyl-CoA synthetase (AceCS) showed a significant match to the query sequences. The 674 amino acid protein encoded by the T. brucei Tb927.8.2520 gene shows 49.6%, 49.2%, and 47.7% identity with the Drosophila melanogaster, Arabidopsis thaliana, and human AceCS.
The T. brucei AceCS gene was expressed in E. coli with an N-terminal polyhistidine tag, using the pET vector system (Novagene). The recombinant AceCS protein (75 kDa) was purified to near homogeneity on Ni 2ϩ nitriloacetic acid-agarose. A specific activity of 0.3 units (mmol⅐min Ϫ1 ) per mg of protein was determined in the direction of acetyl-CoA formation. For each of the 3 substrates involved in the acetyl-CoA production, the Michaelis-Menten curves were hyperbolic with apparent K m values of 80 M for acetate, 400 M for ATP, and 20 M for CoASH ( Fig. S2) . These values are similar to those obtained for other AceCS, including the human enzyme (17) (18) (19) .
AceCS Is an Essential Cytosolic Protein in Procyclic Trypanosomes. A rabbit immune serum raised against the recombinant AceCS protein recognizes a single 75-kDa protein expressed in the procyclic form of T. brucei (see Fig. 3 ). The subcellular localization was determined by a digitonin titration experiment, wherein the different membranes of the procyclic trypanosomes were differentially permeabilized by increasing concentrations of the detergent. A western blot analysis of the soluble and insoluble fractions indicates that AceCS and the cytosolic fumarase (FHc) (20) are released together at 40 g digitonin/mg protein, whereas the glycosomal PPDK (21) and the mitochondrial ASCT (7) are released at much higher digitonin concentrations (200 g and 400 g of digitonin per mg protein, respectively) ( Fig. 3 ). Immunofluorescence analysis of the T. brucei procyclic form using the anti-AceCS immune serum confirmed a homogenous diffuse pattern characteristic for a cytoplasmic localization. We used the pLew100 vector (22) for inducible RNAimediated degradation of the AceCS transcript (23), as described (24, 25) . A recombinant pLew-AceCS-SAS plasmid designed to produce, under the control of tetracycline, hairpin doublestranded RNA molecules specific for AceCS was introduced into the EATRO1125.T7T cell line expressing the tetracycline repressor and T7 RNA polymerase (22, 24) . We generated 2 mutant cell lines ( RNAi AceCS-1 and RNAi AceCS-2), that efficiently repress AceCS expression upon tetracycline induction of RNAi ( Fig. 4A, Lower) . AceCS is essential for the procyclic cells, because both induced RNAi AceCS mutant cell lines die 18 days after tetracycline addition (Fig. 4A ).
AceCS Is Not Involved in Acetate Production. Because AceCS can theoretically function in both directions (acetate or acetyl-CoA production), we first investigated its role in acetate production. The rate of 13 C-enriched acetate produced from D-[1-13 C]glucose metabolism by the RNAi AceCS-1 cell line is not significantly changed upon tetracycline induction (Table S1 ). It has been previously shown that acetyl-CoA produced from Dglucose metabolism in procyclic trypanosomes does not enter the TCA cycle but is rather converted into acetate that is excreted (between 20% and 40% of the excreted end products) (25, 26) . In procyclic trypanosomes, ASCT is involved in acetate production from D-glucose metabolism (27) . However, the rate of acetate production by ⌬asct/⌬asct and induced RNAi ASCT cell lines is only moderately reduced (approximately one-third compared with parental cell lines, see Table S1 ), suggesting that another unknown enzymatic activity is involved in acetate production (7) . AceCS was an obvious candidate. To uncover a possible effect on acetate production under more challenging conditions, we generated the RNAi ASCT/AceCS double mutant cell line for tetracycline-inducible repression of both ASCT and AceCS proteins (Fig. S3 ). Carbon 13 ( 13 C) NMR spectroscopy was used to compare the metabolic end products excreted by 2 independent single RNAi ASCT-cl3 and RNAi ASCT-cl4 mutant clones (7) and the double RNAi ASCT/AceCS mutant cell line. The relative amount of 13 C-enriched acetate produced from D-[1-13 C]-glucose metabolism is equivalent (14%, 14.6%, and 14.2% of the 13 C-enriched excreted end products, respectively) in all 3 lines after 8-12 days of RNAi-induction (Table S1 ). These data suggest that AceCS is not significantly contributing to acetate production and strongly support the view that AceCS functions in the direction of acetyl-CoA production from acetate. AceCS Provides the Acetyl-CoA Precursor for Lipid Biosynthesis. The T. brucei AceCS thus is an essential cytosolic enzyme that seems to produce acetyl-CoA from acetate. To investigate its role in de novo fatty acid biosynthesis, the tetracycline-induced RNAi -AceCS-1 mutant and the parental cell line were incubated in SDM80 medium (devoid of L-threonine) containing [1-14 C]acetate. De novo biosynthesis of phospholipids PC, PI, PE, and neutral lipids is shown in Fig. 4 B and C . Label incorporation into lipids rapidly decreased after tetracycline addition, and lipid biosynthesis was almost completely abolished after 7 days of induction (Fig. 4B ). Cells were still alive at this time point and cell death occurred approximately 18 days after induction (Fig.  4A) . The same results were obtained with the RNAi AceCS-2 cell line. It is noteworthy that the energy metabolism of the RNAi -AceCS-1 cell line is not significantly affected, because the amount of excreted end products from D-[1-13 C]-glucose metabolism is similar before or 9-10 days after tetracyclineincubation (935 versus 912 nmol/h/mg of protein, Table S1 ). To exclude that the observed decrease of lipid biosynthesis was not an indirect consequence of growth phenotype (Fig. 4A ), we used a control with similar growth properties instead of uninduced RNAi AceCS-1 cells. Parental cells were grown in the presence of the cytoskeleton inhibitor nocodazole, which affects cell division. Whereas 1.2 g/mL nocodazole produced a growth curve similar to tetracycline induction of the RNAi AceCS cell lines (Fig. 4A ), de novo lipid biosynthesis from [1-14 C]-acetate was essentially unaffected (Fig. 4C ). This strongly supported our hypothesis that AceCS is providing most of the acetyl-CoA for de novo lipid biosynthesis.
Because acetate is not a physiological carbon source of trypanosomes, the RNAi AceCS-1 cell line was also incubated in SDM80 medium containing L-proline and D-[U-14 C]-glucose. Both lipid precursors, glycerol-3-phosphate and acetyl-CoA, are produced from D-[U-14 C]-glucose. Therefore we compared 14 Clabel incorporation into glycerolipids (PC, PI, PE, and TAG derived from both precursors) with free fatty acids, which only contain the 14 C-label from acetyl-CoA (Fig. 1) . The amounts of free fatty acids produced by the tetracycline-induced RNAi -AceCS-1 cell line after 12 days of induction are 20-fold reduced compared with the parental cell line (Fig. 5A) . This cell line also shows a 16-fold reduction of fatty acid esters obtained by total lipid saponification ( Fig. 5B) , confirming that glucose-derived acetyl-CoA is provided by AceCS. Although glycerolipids (PC, PI, PE, and TAG) are also labeled from the G3P precursor, it is noteworthy that the labeling of these lipids was significantly reduced in the induced RNAi AceCS-1 cell line (4.8, 2.5, 4.2, and 1.8-fold after 12 days of tetracycline induction), consistent with strong reduction of 14 C-labeled fatty acid incorporation in these classes of lipids (Fig. 5A ).
Discussion
The first enzyme in the de novo synthesis pathway of fatty acids, the acetyl-CoA carboxylase, is located in the cytosol. Therefore, acetyl-CoA produced in mitochondria from carbohydrate or amino acid catabolism needs to exit this organelle. All eukaryotes analyzed so far use the citrate/malate shuttle, involving CS and CL, to export acetyl-CoA from mitochondria for supply of cytosolic lipid biosynthesis. This is exemplified by reduction of D-[6-14 C]-glucose-dependent lipid biosynthesis in human cells by RNAi inhibition of CL expression or chemical inhibition of CL activity (SB-204990) (12) . In contrast, no significant difference was observed in 14 C-pyruvate-dependent lipid biosynthesis in 2 human cell lines showing 40-fold difference in acetyl-CoA synthetase (AceCS) activity (17) , indicating that AceCS is not involved in lipid biosynthesis from glucose.
Here, we show that an eukaryotic cell, the procyclic stage of Trypanosoma brucei, uses acetate instead of citrate to transfer acetyl group equivalents across the mitochondrial membranes. In this transfer system, acetate is produced in the trypanosome mitochondrion from acetyl-CoA by ASCT (7, 27) and an alternative unknown step that is currently under investigation. The alternative acetate production step is probably mitochondrial, because acetate production is abolished in the tetracyclineinduced RNAi PDH-E2 cell line lacking the mitochondrial pyruvate dehydrogenase complex (16) . Then acetate crosses the mitochondrial inner membrane by passive diffusion [acetate being a lipophilic weak acid in its protonated form (28) ] or through an unknown mitochondrial carrier or exchanger. Once in the cytosol, acetate is converted into acetyl-CoA by the ''AMP-forming'' AceCS. The essential role of AceCS in de novo lipid biosynthesis was demonstrated in this report by the 20-fold decrease of radiolabel incorporation into fatty acids from the glucose precursor when AceCS expression was inhibited by RNAi. Very little is known about lipid requirements of procyclic trypanosomes, however, supplementation with lipids or FBS is essential for optimal growth (29) . The RNAi AceCS cell lines die approximately 18 days after RNAi induction, suggesting that de novo lipid biosynthesis is essential and not complemented by uptake of lipids present in the serum-containing medium. The citrate/malate shuttle is apparently not functional, at least in the procyclic stage of the parasite, because no rescue of the RNAi -AceCS phenotype is observed.
In other model organisms, AceCS is an ubiquitous cytosolic and/or mitochondrial enzyme, whose main role is to activate the lipophilic acetate into the metabolic precursor acetyl-CoA (30) . The single AceCS gene in the T. brucei genome encodes a cytosolic enzyme catalyzing exactly this biochemical reaction. However, the substrate of the cytosolic T. brucei AceCS (acetate) is produced in the mitochondrion, whereas in other organisms acetate is produced in the same subcellular compartment or is taken up from the extracellular environment. For example, in E. coli and other prokaryotes, glucose is first converted into acetate (and eventually excreted). When glucose becomes limiting, extracellular acetate is assimilated and activated into acetyl-CoA by AceCS to feed gluconeogenesis and the TCA cycle (31) . In the cytosol of Saccharomyces cerevisiae and other yeasts, pyruvate produced from glycolysis can be converted into acetaldehyde and acetate, which is activated into acetyl-CoA by the cytosolic AceCS; this pathway is a bypass of the conventional pyruvate dehydrogenase complex also expressed in yeasts (32) . The yeast cytosolic AceCS, also translocated to the nucleus, is the source of acetyl-CoA for the nuclear histone acetyltransferases (33) . In mammals, there are several occasions in which acetate must be activated by AceCS to be metabolized, however, as opposed to trypanosomes, acetate is never produced in mitochondria. For instance, (i) the liver activates acetate produced by bacteria in the colon (34) or (ii) produced from ethanol degradation in the cytosol, (iii) the cytosolic acetyl-CoA hydrolase activities produce significant amount of acetate, which can be salvaged by AceCS to reenter the metabolism (35) , and (iv) in neurons, the cytosolic acetylcholinesterases breakdown the neurotransmitter acetylcholine into choline and acetate that must be reactivated by AceCS to replenish acetylcholine stores (36) . The T. brucei genome contains putative or characterized genes for all of the key enzymes of the citrate/malate shuttle, including CS and CL, the mitochondrial and cytosolic malate dehydrogenases and a putative tricarboxylate exchanger (37), however the putative CL genes is not essential as shown by knock-out strains (Fig. 2) . In contrast, the tetracycline-induced RNAi AceCS cell lines show an almost complete absence of 14 C-incorporation into lipids when D-[U-14 C]-glucose is the main carbon source and die after 18 days, indicating that CL and consequently the citrate/ malate shuttle are not used in procyclic trypanosomes to feed lipid biosynthesis. In addition, we have no proof that the Tb927.8.6820 gene product is a bona fide CL gene. First, the CL activity is not detectable in extracts from procyclic and bloodstream forms of T. brucei; second, the Tb927.8.6820 gene (annotated as CL gene in GeneDB) shows a low level of similarity with CL from other organisms (the best hit in GenBank was 27% identity with the Roseobacter litoralis CL); and third, the MITOP program detected a signal peptide with high probability in the products of the Tb927.8.6820 gene and the orthologous T. cruzi and Leishmania braziliensis genes (0.7, 0.96, and 0.99, respectively), suggesting that these proteins are expressed in the mitochondrion. This observation and the moderate growth phenotype of ⌬cl/⌬cl lines not explained by any change of 14 C-incorporation into lipids from D-[U-14 C]-glucose suggest an alternative function of the Tb927. 8 .6820 gene that is currently under investigation.
Although the citrate/malate shuttle is apparently not functional, we speculate that mitochondrial citrate production is important for other reasons. A significant flux through the CS reaction is indicated by 100-fold citrate accumulation in aconitase knock-out mutant lines (26) . The presence of a cytosolic aconitase activity (38) and the recent identification of a glycosomal NADP-dependent isocitrate dehydrogenase (39) suggest that citrate produced in the mitochondrion might be transferred to the cytosol, where it can be converted to isocitrate by the cytosolic aconitase activity. Once transferred to the glycosomes, by a putative isocitrate/2-ketoglurate carrier (Tb10.389.0690) present in the glycosomal proteome (39) , isocitrate could feed the glycosomal NADP-dependent isocitrate dehydrogenase to produce NADPH required by all oxidative stress defense systems. The relevance of this alternative glycosomal NADPHproducing pathway is under investigation.
Methods
Trypanosome Culture and Transfection. The procyclic form of the EATRO1125.T7T and AnTat1.1-1313 strain was cultivated at 27°C in SDM79 or SDM80 media supplemented with 10% (vol/vol) of heat-inactivated FCS, and 7.5 g/mL hemin, in the presence of 10 g/mL neomycine and 25 g/mL hygromycin (EATRO1125.T7T) or 15 g/mL neomycine and 2.5 g/mL phleomycin (AnTat1.1-1313) (15) . Procyclic AnTat1.1 1313 were grown in SDM79 as above plus 10 mM glycerol, 23.8 mM NaHCO 3 and 100 U/mL penicillin, and selected in 2.5 g/mL phleomycin, 10 g/mL blasticidin, and 1 g/mL puromycin. The parental EATRO1125 and AnTat1.1 cell lines were derived from the same trypanosome stock (40) . Transfection of procyclic trypanosomes was performed as described before (7) .
Inhibition of Gene Expression by RNA Interference and Gene Knock-Out.
The inhibition by RNAi of the expression of the ASCT and AceCS genes in the EATRO1125.T7T procyclic form of T. brucei was performed as previously described (7, (22) (23) (24) (25) . See SI Methods for more details. Replacement of the CL gene by the blasticidin and puromycin resistance markers via homologous recombination was performed by transfecting the AnTat1.1-1313 procyclic cell line with PCR amplified resistance markers using long primers homologous over 50 bp to CL UTR sequences. Correct homologous integration of the resistance markers in the resulting drug resistant clones was analyzed by PCR (see Fig. S1 ). RNA was isolated from 10 9 cells by using 5 mL of TriZol LS (Invitrogen). RNA integrity was checked on an agarose gel and quantified using a nanodrop. Total RNA (5 g) was DNase I-treated by using the TURBO DNA-free TM kit (Ambion) and converted to cDNA by using oligo(dT)12-18 primers (Invitrogen) and SuperScript™ II Reverse Transcriptase. Primers used for RT-PCR are shown in Table S2 .
Production of Recombinant AceCS and Specific Polyclonal Antibodies.
For expression of the recombinant T. brucei AceCS in E. coli and AceCS activity test, see SI Methods.
Lipid Labeling from [1-14 C]-acetate and [U-14 C]-glucose. Aliquots of 10 8 cells in the late exponential phase were incubated for 16 h in 5 mL of modified SDM80 medium without L-threonine (15) containing 10 mM D-glucose, 1 mM acetate, and 10 Ci of [1-14 C]-acetate (58.9 mCi/mmol) or containing 3 mM D-glucose and 5 Ci of D-[U-14 C]-glucose (287 mCi/mmol). Cells were checked microscopically for viability several times during the incubation. Subsequently, lipids were extracted by chloroform:methanol (2:1, vol/vol) and analyzed as described before (41, 42) . See SI Methods for more details.
Digitonin Permeabilization. Digitonin titration was performed as previously described (43) . See SI Methods for more details.
Western Blot Analyses. Total protein lysates of wild type or mutant procyclic trypanosomes (5 ϫ 10 6 cells) were separated by SDS/PAGE (12%) and blotted on Immobilon-P™ (Millipore). Immunodetections were performed using as primary antibodies mouse anti-AceCS (1:100), rabbit anti-ASCT (1:500) (7), mouse anti-FHc (1:100) (20) , and rabbit anti-PPDK (1:100) (21) . As secondary antibodies, anti-mouse or anti-rabbit IgG conjugated to horseraddish peroxidase (Bio-Rad) were used. The ECL kit was used according to the manufacturer's instructions (GE Healthcare).
Nuclear Magnetic Resonance Experiments. 13 C-enriched end products excreted by parental and RNAi mutant cell lines from D-[1-13 C]-glucose metabolism was performed as described before (20, 25) . See SI Methods for more details.
